130 related articles for article (PubMed ID: 21152841)
1. [Endometrial polyps: clinical and epidemiological aspects and analysis of polymorphisms].
Miranda SM; Gomes MT; Silva ID; Girão MJ
Rev Bras Ginecol Obstet; 2010 Jul; 32(7):327-33. PubMed ID: 21152841
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development.
Junqueira MG; da Silva ID; Nogueira-de-Souza NC; Carvalho CV; Leite DB; Gomes MT; Baracat EC; Lopes LA; Nicolau SM; Gonçalves WJ
Int J Gynecol Cancer; 2007; 17(1):229-32. PubMed ID: 17291258
[TBL] [Abstract][Full Text] [Related]
3. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.
Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM
Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515
[TBL] [Abstract][Full Text] [Related]
4. Analysis of differential genetic expression in endometrial polyps of postmenopausal women.
Troncon JK; Meola J; Candido-Dos-Reis FJ; Poli-Neto OB; Nogueira AA; Rosa-E-Silva JC
Climacteric; 2017 Oct; 20(5):462-466. PubMed ID: 28622040
[TBL] [Abstract][Full Text] [Related]
5. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies.
Wang JH; Zhao J; Lin J
J Minim Invasive Gynecol; 2010; 17(1):53-8. PubMed ID: 20129333
[TBL] [Abstract][Full Text] [Related]
6. Clear cell adenocarcinoma present exclusively within endometrial polyp: report of two cases.
Ishida M; Iwai M; Yoshida K; Kagotani A; Okabe H
Int J Clin Exp Pathol; 2014; 7(4):1757-63. PubMed ID: 24817975
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.
Leite DB; Junqueira MG; de Carvalho CV; Massad-Costa AM; Gonçalves WJ; Nicolau SM; Lopes LA; Baracat EC; da Silva ID
Steroids; 2008 Jul; 73(6):676-80. PubMed ID: 18384825
[TBL] [Abstract][Full Text] [Related]
8. Endometrial polyps. A clinical study of 245 cases.
Reslová T; Tosner J; Resl M; Kugler R; Vávrová I
Arch Gynecol Obstet; 1999; 262(3-4):133-9. PubMed ID: 10326632
[TBL] [Abstract][Full Text] [Related]
9. What is the influence of cyclooxygenase-2 on postmenopausal endometrial polyps?
Pereira AK; Garcia MT; Pinheiro W; Ejzenberg D; Soares JM; Baracat EC
Climacteric; 2015; 18(4):498-502. PubMed ID: 25242379
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.
Costa-Paiva L; Godoy CE; Antunes A; Caseiro JD; Arthuso M; Pinto-Neto AM
Menopause; 2011 Dec; 18(12):1278-82. PubMed ID: 21926931
[TBL] [Abstract][Full Text] [Related]
11. Roles of sonography and hysteroscopy in the detection of premalignant and malignant polyps in women presenting with postmenopausal bleeding and thickened endometrium.
Cavkaytar S; Kokanali MK; Ceran U; Topcu HO; Sirvan L; Doganay M
Asian Pac J Cancer Prev; 2014; 15(13):5355-8. PubMed ID: 25041001
[TBL] [Abstract][Full Text] [Related]
12. Steroid hormone receptor profile of premenopausal endometrial polyps.
Zitao Liu ; Kuokkanen S; Pal L
Reprod Sci; 2010 Apr; 17(4):377-83. PubMed ID: 20228382
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
14. Endometrial polyps: when to resect?
de Azevedo JM; de Azevedo LM; Freitas F; Wender MC
Arch Gynecol Obstet; 2016 Mar; 293(3):639-43. PubMed ID: 26305029
[TBL] [Abstract][Full Text] [Related]
15. Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor-positive breast cancer.
López DM; Fernández YG; Sánchez AV; Alvarez MI; Reynaldo MI; Delgado RC
Menopause; 2013 Jan; 20(1):64-71. PubMed ID: 22968254
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic workup for postmenopausal bleeding: a randomised controlled trial.
van Hanegem N; Breijer MC; Slockers SA; Zafarmand MH; Geomini P; Catshoek R; Pijnenborg J; van der Voet LF; Dijkhuizen F; van Hoecke G; Reesink-Peters N; Veersema S; van Hooff M; van Kesteren P; Huirne JA; Opmeer BC; Bongers MY; Mol B; Timmermans A
BJOG; 2017 Jan; 124(2):231-240. PubMed ID: 27225535
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifen.
Cohen I; Azaria R; Bernheim J; Shapira J; Beyth Y
Cancer; 2001 Sep; 92(5):1151-5. PubMed ID: 11571728
[TBL] [Abstract][Full Text] [Related]
18. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
[TBL] [Abstract][Full Text] [Related]
19. The progesterone receptor gene polymorphism, PROGINS, may be a factor related to the development of uterine fibroids.
Gomes MT; Castro Rde A; Villanova FE; da Silva ID; Baracat EC; de Lima GR; Girão MJ
Fertil Steril; 2007 May; 87(5):1116-21. PubMed ID: 17224149
[TBL] [Abstract][Full Text] [Related]
20. Risk of malignancy on suspicion of polyps in menopausal women.
Bel S; Billard C; Godet J; Viviani V; Akladios C; Host A; Faller E; Boisrame T; Hummel M; Baldauf JJ; Lecointre L; Garbin O
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():138-142. PubMed ID: 28763739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
